A genome-wide association study identifies a gene network associated with paranoid schizophrenia and antipsychotics-induced tardive dyskinesia / A. S. Levchenko, A. Kanapin, Samsonova A. I. Samsonova [et al.] // Progress in Neuro-Psychopharmacology and Biological Psychiatry. — 2021. — Vol. 105. — [110134, 12 p.]. — URL: https://doi.org/10.1016/j.pnpbp.2020.110134
Association of PIP4K2A Polymorphisms with Alcohol Use Disorder / O. Yu. Fedorenko, E. V. Mikhalitskaya, V. A. Toshchakova [et al.] // Genes. — 2021. — Vol. 12, iss. 10. — [1642, 7 p.]. — URL: https://doi.org/10.3390/genes12101642
Нормативная оценка когнитивных функций по шкале «Краткая оценка когнитивных функций у пациентов с шизофренией» (BACS) в томской популяции: конституциональные факторы вариативности = Normative Assessment of Cognitive Functions with on the Brief Assessment of Cognition In Schizophrenia (BACS) Scale in the Tomsk Population: Constitutional Factors of Variability / А. Н. Корнетов, К. Г. Языков, Е. Г. Корнетова [и др.] // Сибирский психологический журнал. — 2021. — № 82. — [С. 137-152]. — URL: https://www.elibrary.ru/item.asp?id=47556511
Полиморфный вариант RS10828317 гена PIP5K2A у больных с алкогольной зависимостью и аффективными расстройствами = PIP5K2A (rs10828317) polymorphism in patients with alcohol dependence and affective disorders / Е. В. Михалицка, Н. М. Вялова, О. Ю. Федоренко [и др.] // Неврология, нейропсихиатрия, психосоматика. — 2021. — Т. 13, № 3. — [С. 48-52]. — URL: https://doi.org/10.14412/2074-2711-2021-3-48-52
Rare single nucleotide variants in COL5A1 promoter do not play a major role in keratoconus susceptibility associated with rs1536482 / L. O. Skorodumova, A. V. Belodedova, E. I. Sharova [et al.] // BMC Ophthalmology. — 2021. — Vol. 21, iss. 1. — [357, 9 p.]. — URL: https://doi.org/10.1186/s12886-021-02128-6
Association of Cholinergic Muscarinic M4 Receptor Gene Polymorphism with Schizophrenia / I. V. Pozhidaev, A. S. Boyko, A. J. M. Loonen [et al.] // The Application of Clinical Genetics. — 2020. — Vol. 13. — [P. 97-105]. — URL: https://doi.org/10.2147/TACG.S247174
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia / I. V. Pozhidaev, D. Z. Paderina, O. Yu. Fedorenko [et al.] // Frontiers in Molecular Neuroscience. — 2020. — Vol. 13. — [63, 8 p.]. — URL: https://doi.org/10.3389/fnmol.2020.00063
Association of ANKK1 polymorphism with antipsychotic‐induced hyperprolactinemia / O. Yu. Fedorenko, D. Z. Paderina, A. J. M. Loonen [et al.] // Human Psychopharmacology: Clinical and Experimental. — 2020. — Vol. 35, iss. 4. — [e2737, 8 p.]. — URL: https://doi.org/10.1002/hup.2737
Association between 8 P‐glycoprotein (MDR1/ABCB1) gene polymorphisms and antipsychotic drug‐induced hyperprolactinaemia / L. M. Geers, I. V. Pozhidaev, S. A. Ivanova [et al.] // British Journal of Clinical Pharmacology. — 2020. — Vol. 86, iss. 9. — [P. 1827-1835]. — URL: https://doi.org/10.1111/bcpt.13173
Федоренко, О. Ю. Новый взгляд на генетику нейрокогнитивного дефицита при шизофрении = A new look at the genetics of neurocognitive deficits in schizophrenia / О. Ю. Федоренко, С. А. Иванова // Журнал неврологии и психиатрии им. C. C. Корсакова. — 2020. — Т. 120, № 8. — [С. 183-192]. — URL: https://www.elibrary.ru/item.asp?id=43921865
No evidence so far of a major role of AKT1 and GSK3B in the pathogenesis of antipsychotic‐induced tardive dyskinesia / A. Levchenko [et al.] // Human Psychopharmacology: Clinical and Experimental. — 2019. — Vol. 34, iss. 1. — [e2685, 5 p.]. — URL: https://doi.org/10.1002/hup.2685
A sexy approach to pacemaking: differences in function and molecular make up of the sinoatrial node / U. Doris [et al.] // Histology and Histopathology. — 2019. — Vol. 34, iss. 11. — [P. 1255-1268]. — URL: http://dx.doi.org/10.14670/HH-18-115
Opening up new horizons for psychiatric genetics in the Russian Federation: moving toward a national consortium / O. Yu. Fedorenko [et al.] // Molecular Psychiatry. — 2019. — Vol. 24, iss. 8. — [P. 1099-1111]. — URL: https://doi.org/10.1038/s41380-019-0354-z
Гормоны стресса у мужчин, профессиональная деятельность которых носит офисный и чрезвычайный экстремальный характер = Stress hormones in men whose professional activities are either office-based or of an extreme emergency nature / Е. В. Епимахова, Л. А. Левчук, О. Ю. Федоренко [и др.] // Якутский медицинский журнал. — 2019. — № 2 (66). — [С. 20-22]. — URL: https://doi.org/10.25789/YMJ.2019.66.05
A pharmacogenetic study of patients with schizophrenia from West Siberia gets insight into dopaminergic mechanisms of antipsychotic-induced hyperprolactinemia / D. Z. Osmanova, M. B. Freydin, O. Yu. Fedorenko [et al.] // BMC Medical Genetics. — 2019. — Vol. 20. — [47, 10 p.]. — URL: https://doi.org/10.1186/s12881-019-0773-3
Genetic polymorphisms of PIP5K2A and course of schizophrenia / E. Poltavskaya, O. Yu. Fedorenko, N. M. Vyalova [et al.] // BMC Medical Genetics. — 2020. — Vol. 21. — [171, 9 p.]. — URL: https://doi.org/10.1186/s12881-020-01107-w
Pharmacogenetics of tardive dyskinesia in schizophrenia: The role of CHRM1 and CHRM2 muscarinic receptors / A. S. Boyko [et al.] // The World Journal of Biological Psychiatry. — 2018. — Latest Articles. — [7 p.]. — URL: https://doi.org/10.1080/15622975.2018.1548780
Polymorphisms of Catechol-O-Methyl Transferase (COMT) Gene in Vulnerability to Levodopa-Induced Dyskinesia / S. A. Ivanova [et al.] // Journal of Pharmacy and Pharmaceutical Sciences (JPPS). — 2018. — Vol. 21. — [P. 340-346]. — URL: http://dx.doi.org/10.18433/jpps29903
Prolactin gene polymorphism (- 1149 G/T) is associated with hyperprolactinemia in patients with schizophrenia treated with antipsychotics / S. A. Ivanova [et al.] // Schizophrenia Research. — 2017. — Vol. 182. — [P. 110–114]. — URL: http://doi.org/10.1016/j.schres.2016.10.029
Hyperprolactinemia and CYP2D6, DRD2 and HTR2C genes polymorphism in patients with schizophrenia / O. Yu. Fedorenko [et al.] // Physiology and Pharmacology. — 2017. — Vol. 21, iss. 1. — [P. 25-33]. — URL: http://phypha.ir/ppj/browse.php?a_id=1205&